| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S F Leibowitz, C Rossaki. L-Dopa feeding suppression: effect on catecholamine neurons of the perifornical lateral hypothalamus. Psychopharmacology. vol 61. issue 3. 1979-08-16. PMID:109892. |
l-dopa's action was partially antagonized by separate injections of the dopaminergic blocker haloperidol (58% blockade) and the beta-adrenergic blocker propranolol (38% blockade). |
1979-08-16 |
2023-08-11 |
rat |
| P R Scraggs, R M Ridle. The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset. Psychopharmacology. vol 62. issue 1. 1979-07-28. PMID:155838. |
checking behaviour is blocked in a dose dependent manner by 0.03--0.18 mg/kg haloperidol but not by propranolol, aceperone or diazepam, suggesting dopaminergic mediation of this behaviour. |
1979-07-28 |
2023-08-11 |
marmoset |
| V P Georgiev, V L Markovska, B P Petkov. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission. Acta physiologica et pharmacologica Bulgarica. vol 4. issue 3. 1979-07-25. PMID:220843. |
the agents acting on the dopaminergic transmission also reduce apomorphine stereotypies in the following order: haloperidol (20;2), l-dopa (500 mg/kg, i. p.), alpha-methylparatyrosine (150 mg/kg, i. p.) diethyldithiocarbamate (200). |
1979-07-25 |
2023-08-11 |
mouse |
| S E Robinson, D Malthe-Sørenssen, P L Wood, J Commission. Dopaminergic control of the septal-hippocampal cholinergic pathway. The Journal of pharmacology and experimental therapeutics. vol 208. issue 3. 1979-06-29. PMID:430364. |
blockade of dopaminergic receptors by intraseptal haloperidol or destruction of dopaminergic terminals by intraseptal 6-hydroxydopamine results in an increase in tr(ach) in the hippocampus. |
1979-06-29 |
2023-08-11 |
Not clear |
| F Moos, P Richar. Effects of dopaminergic antagonist and agonist on oxytocin release induced by various stimuli. Neuroendocrinology. vol 28. issue 2. 1979-06-11. PMID:431776. |
(1) haloperidol, a dopaminergic antagonist was injected i.p. |
1979-06-11 |
2023-08-11 |
rat |
| K L McGilliard, A E Takemor. The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression. European journal of pharmacology. vol 54. issue 1-2. 1979-05-23. PMID:33817. |
blockade of dopaminergic receptors by haloperidol or pimozide produced a potentiation of morphine analgesia, while stimulation of dopaminergic activity by l-dopa methyl ester inhibited morphine analgesia. |
1979-05-23 |
2023-08-11 |
Not clear |
| C A Greer, H P Alper. Differential neurohumoral modulation of myoclonic and clonic seizures. Archives internationales de pharmacodynamie et de therapie. vol 236. issue 1. 1979-05-23. PMID:34368. |
dopaminergic drugs (apomorphine and haloperidol) only affected myoclonus, whereas cholinergic (pilocarpine and scopolamine), gabaergic (aoaa and bicuculline), and serotonergic (pcpa) compounds principally influenced clonus. |
1979-05-23 |
2023-08-11 |
mouse |
| L A Baez, D K Burt, J Granneman, C Shankli. Dopaminergic antagonism and catalepsy in the developing rat. European journal of pharmacology. vol 54. issue 1-2. 1979-05-23. PMID:570505. |
the cataleptic effect of the dopaminergic blockers spiroperidol and haloperidol was investigated in developing rats. |
1979-05-23 |
2023-08-11 |
rat |
| S K Quadri, C Pierson, H G Spie. Effects of centrally acting drugs on serum prolactin levels in rhesus monkeys. Neuroendocrinology. vol 27. issue 3-4. 1979-03-24. PMID:104186. |
prl elevations of the highest magnitude and longest duration were produced by haloperidol, which blocks both adrenergic and dopaminergic receptors. |
1979-03-24 |
2023-08-11 |
monkey |
| R M Quock, B G Weic. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia. The Journal of pharmacy and pharmacology. vol 31. issue 1. 1979-03-13. PMID:32362. |
the hyperthermic and behavioural responses of both agents were reduced by the 5-hydroxytryptamine (5-ht) uptake inhibitor, fluoxetine, potentiated by the monoamine oxidase inhibitor, pheniprazine, and unaltered by the dopaminergic antagonist, haloperidol. |
1979-03-13 |
2023-08-11 |
Not clear |
| B S Bunney, A A Grac. Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life sciences. vol 23. issue 16. 1979-02-23. PMID:31529. |
acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. |
1979-02-23 |
2023-08-11 |
Not clear |
| N G Bacopoulos, G Bustos, D E Redmond, J Baulu, R H Rot. Regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment. Brain research. vol 157. issue 2. 1979-02-21. PMID:31230. |
regional sensitivity of primate brain dopaminergic neurons to haloperidol: alterations following chronic treatment. |
1979-02-21 |
2023-08-11 |
Not clear |
| G U Corsini, M Del Zompo, A Spissu, A Mangoni, G L Gess. Parkinsonism by haloperidol and piribedil. Psychopharmacology. vol 59. issue 2. 1979-02-21. PMID:103114. |
the results suggest that low doses of the da-agonist potentiate the extrapyramidal side effects of haloperidol by acting on self-inhibitory da receptors, thereby blocking the compensatory increase in dopaminergic firing elicited by the neuroleptic agent. |
1979-02-21 |
2023-08-11 |
Not clear |
| K L Davis, L E Hollister, W C Frit. Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol. Life sciences. vol 23. issue 15. 1979-02-21. PMID:723433. |
induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol. |
1979-02-21 |
2023-08-11 |
Not clear |
| K Hermanse. Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas. Diabetologia. vol 15. issue 4. 1979-01-26. PMID:710756. |
haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas. |
1979-01-26 |
2023-08-11 |
Not clear |
| K Hermanse. Haloperidol, a dopaminergic antagonist: somatostatin-like inhibition of glucagon and insulin release from the isolated, perfused canine pancreas. Diabetologia. vol 15. issue 4. 1979-01-26. PMID:710756. |
the effect of haloperidol, a dopaminergic antagonist, on insulin and glucagon secretion was investigated using the isolated, perfused canine pancreas. |
1979-01-26 |
2023-08-11 |
Not clear |
| A J Puech, P Simon, J R Boissie. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects. European journal of pharmacology. vol 50. issue 4. 1978-12-27. PMID:29758. |
haloperidol, metoclopramide, prochlorperazine, sultopride, and tiapride, could block both types of dopaminergic receptors with equal intensity whatever the dose. |
1978-12-27 |
2023-08-11 |
Not clear |
| b' V Schreiber, T Pribyl, J Jahodov\\xc3\\xa. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine. Physiologia Bohemoslovaca. vol 27. issue 4. 1978-11-27. PMID:151287.' |
dopaminergic control of adenohypophyseal growth after oestrogens: negative results with l-dopa, ro-4-4602, alpha-methyl-dopa, apomorphine, haloperidol, pyridoxine and cyproheptadine. |
1978-11-27 |
2023-08-11 |
rat |
| D Burns, J P Brady, K Kuruvill. The acute effect of haloperidol and apomorphine on the severity of stuttering. Biological psychiatry. vol 13. issue 2. 1978-09-29. PMID:667231. |
the increased fluency after haloperidol, an agent which is felt to turn off the dopaminergic system via postsynaptic blockade, and after low-dose apomorphine, which appears to inhibit the dopamine system via presynaptic effects is consistent with a role for central dopaminergic systems in the pathogenesis of stuttering. |
1978-09-29 |
2023-08-11 |
human |
| J S Kizer, J Humm, G Nicholson, G Greeley, W Youngbloo. The effect of castration, thyroidectomy and haloperidol upon the turnover rates of dopamine and norepinephrine and the kinetic properties of tyrosine hydroxylase in discrete hypothalamic nuclei of the male rat. Brain research. vol 146. issue 1. 1978-07-15. PMID:25696. |
from these results 4 conclusions were drawn: (1) following halperidol, castration, and thyroidectomy there are increases in the activity of dopaminergic terminals within the me; (2) castration, haloperidol and thyroidectomy may influence the activity of dopaminergic terminals within the me by different mechanisms; (3) changes in tyrosine hydroxylase and turnover of catecholamines within the me may occur independently of changes in prolactin levels; and (4) local recurrent afferent circuits may exist in the arcuate nucleus region of the hypothalamus. |
1978-07-15 |
2023-08-11 |
rat |